t Abstract J Levels of morphine, 6-monoacetylmorphine (MAM) and codeine in hair in both clinical and workplace subjects are presented. Aggressive wash procedures, consisting of 1 isopropanol wash, three 30-rain, and two 1-h buffer washes, followed by digestion, extraction and confirmation of digested samples, resulted in values from the cutoff of 2 ng morphine/10 mg hair to greater than 200 ng/10 mg hair. Both morphine and MAM were present above the cutoff in all hair samples from 69 clinical subjects. Only 39 of the 69 heroin-using subjects had urine tests positive for 6-MAM. In a study of morphine in hair following poppy seed consumption, ten subjects ingested 150 g of poppy seed over 3 weeks. Urine samples were collected on the days of poppy seed ingestion and hair samples were taken in the 5th week of the study. The range among the 10 subjects of the highest urine value for each subject was 2929 to 13,827 ng morphine/mL. Hair morphine levels were 0.05-0.48 ng/10 mg hair (average 0.17 ng/10 mg hair). Hair opiate levels of workplace subjects ranged somewhat lower than those of clinical subjects. While all clinical hair samples contained MAM, many workplace samples did not. From workplace samples, a maximum amount of morphine likely to be present from codeine use was 0-3.7% of the codeine in the hair.
Introduction
Hair analysis for opiates offers major advantages over urinalysis, including the reliable presence of the heroin metabolite 6-monacetylmorphine (MAM) in the hair of heroin users (1) . In contrast, urine of heroin users very often contains no MAM. Further, morphine in urine in the absence of MAM may be due to poppy seed or codeine use (2) . In the present paper, we present opiate analysis results of heroin clinic patients and workplace (mainly pre-employment) subjects. In addition, we "Author to whom correspondence should be addressed: E-mail: virginiah@psychemedics.com examine the extent of morphine presence in hair from codeine ingestion as evidenced by codeine content in the hair, and in a separate study, demonstrate the amount of morphine that is present in hair from poppy seed ingestion. Thus, the paper presents multiple aspects of hair analysis for opiates, including methodology issues such as aggressive prolonged aqueous washing and recommended extraction methods and the application of these methods to hair samples from both clinical and workplace populations as well as from subjects ingesting codeine and poppy seed.
Use of different analytical approaches by various laboratories for analyzing opiates in hair has resulted in considerable inconsistency in results. After surveying analytical procedures for determination of opiates in hair, one author concluded that methanolic and enzymatic digestion methods are "certainly the best procedures" for recovering morphine, codeine, and MAM from hair (3) . Using methanolic procedures, three laboratories reported morphine values in heroin users' hair of 0.5-52.2 ng/10 mg hair and MAM values of 0.6-101 ng/10 mg hair (4) (5) (6) . These laboratories used methanol at elevated temperatures (40-56~ overnight or for 18 h. The results (on a total of 50 subjects) were obtained without extensive aqueous washing of the hair before the methanol extraction. Another laboratory, using acetonitrile overnight at room temperature, has reported much lower opiate concentrations in hair of heroin clinic patients and concluded as a result that hair analysis was not a good matrix for measuring recidivism in heroin use (7) . This conclusion can have serious consequences, such as discouraging use of hair testing in an area that may particularly benefit from the advantages that hair analysis offers in detection of opiate use. In the present paper, as a contribution to this discussion, we present large collections of data resulting from analysis for opiates in hair from various types of populations. The morphine, MAM, and codeine results presented here were obtained using this laboratory's methods: enzymatic digestion preceded by aggressive aqueous washing. Potential hydrolysis of MAM during the digestion step, another methods issue, is also investigated.
Methods

Chronic opiate users
Drug-using subjects at four rehabilitation clinics in the Southern California area participated in the study. The protocols were reviewed and monitored by Quorum Review, Inc. (Seattle, WA). Subject urine specimens were collected prior to hair being collected using the following schedule: a urine specimen and brief qualitative self-report were collected at first encounter with the subject; if the subject's urine specimen tested positive for any of the SAMHSA-5 drugs (cocaine, opiates, phencyclidine, amphetamines, and marijuana), a second urine sample was collected 7-10 days following the first urine sample collection, and a hair specimen was collected 14-21 days following the first urine. Hair samples were cut from the vertex region of the head, near the scalp, and placed in a collection container that identified the root end of the sample.
The results comprising the data of screened and confirmed positive urine and hair samples from the 69 subjects included samples from 52 males and 17 females, 20 Caucasians, 13 African Americans, and 36 Hispanics. The age range of the participants was 20 to 61 years, with body weights ranging from 110 to 300 pounds.
Negative subjects
Urine samples from 73 non-drug-using subjects were collected twice weekly for 5 weeks. Hair samples were taken one week after the final urine sample. The protocols were reviewed and monitored by Quorum Review, Inc.
Urinalysis
Urine samples were screened by EMIT (Dade Behring, Cupertino, CA) using a cutoff of 300 ng morphine/mL and confirmed by gas chromatography-mass spectrometry (GC-MS) at a SAMHSA-certified laboratory using cutoffs of 2000 ng/mL morphine and 10 ng/mL MAM. Results for the MAM were reported as positive or negative, with quantitative results not provided.
Hair screening tests
The hair analysis screening was performed using Psychemedics' proprietary radioimmunoassay (RIA), an FDAcleared assay system (8) . For the hair screening assay, an aliquot of 7-9 mg of hair, up to 3.9 cm long from the root, was weighed and enzymatically digested with a patented procedure utilizing Proteinase K and dithiothreitol for 2 h at pH 9.5 (9), prior to analysis by RIA. The high pH of the digestion used for the screening assay has an advantage of faster digestion and is convenient for this purpose where metabolites are not quantified. This is in contrast with preparation of positive samples for confirmation, where the digestion is performed at low pH (pH 6.65. for opiate confirmations) and requires 6 h. Following digestion and neutralization, aliquots of the samples were tested in the screening assays for the presence of morphine as well as for the other four SAMHSA-5 drugs.
Workplace testing samples
The routine workplace testing data include head hair samples that tested positive by the FDA-cleared RIA. Workplace testing samples include, primarily, samples for pre-employment screening as well as some samples for random or scheduled employee testing. Such screen-positive samples were then reweighed, washed, and confirmed by liquid chromatography (LC)-MS-MS by the procedures described later. The results are from the head hair samples received by the laboratory over a 10-month period.
Analytical procedures for confirmation testing
The wash procedure used for the hair testing, as previously described (10) , included a 15-rain isopropanol wash and 3.5 h of aqueous dilute buffer washing. First, dry isopropanol (2 mL) was added to about 12 mg of hair in 12-x 75-ram tubes; the tubes were shaken vigorously at 37~ for 15 rain, and the isopropanol was removed and discarded. Then 2 mL of 0.01M phosphate buffer/0.1% BSA (pH 6) was added to the hair samples in the tubes and the tubes shaken vigorously for 30 min at 37~ after which the buffer was removed and discarded. Three such 30-min washes were performed, followed by two 60-min washes using the same conditions. The buffer from the last 60-rain wash was saved for analysis by RIA. After the final (fifth) phosphate buffer wash and removal of the buffer, the hair sample was enzymatically digested at pH 6.65, as described previously (11) , prior to confirmation by LC-MS-MS.
The amount of drug per 10 mg hair in the last wash (determined by RIA) is multiplied by 5 for morphine analyses, and this result is subtracted from the amount of drug per 10 mg hair in the hair digest. The result of subtracting the indicated multiple of the last wash drug value from the digest value is termed the wash criterion and is an underestimate of the amount of drug that would remain in the hair if five additional 1-h washes were to be applied. If the resulting value is less than the cutoff for the parent drug, the result is considered negative (10) . The parent-drug cutoff value for morphine is 2 ng/10 mg hair.
To determine the rate of hydrolysis of MAM to morphine during the low-pH digestion prior to confirmation, hair samples were spiked with MAM before and after digestion. The amounts of MAM and morphine found in four samples spiked with MAM after digestion were 22.93 + 0.76 ng/10 mg hair and 0.55 + 0.09 ng/10 mg hair, respectively. When the same amount of MAM was added to 4 samples before digestion, the resulting MAM and morphine values were 18.39 + 1.24 ng/10 mg hair and 2.37 + 0.27 ng/10 mg hair, respectively. Thus the hydrolysis of MAM to morphine during the digestion step prior to confirmation av- Following digestion, the samples were centrifuged, and the supernatant fractions were extracted using Cerex Polychrom PSCX solid-phase extraction columns. The samples were not derivatized before analysis by LC-MS-MS. Analysis was performed on a triple quadrupole API 2000 Perkin Elmer Sciex (Thornhill, Ontario, Canada) MS equipped with an atmospheric pressure ionization source via an ionspray interface. For LC, a binary pump with an ISS 200 Perkin Elmer autosampler was used. The mobile phase was a mixture of water and acetonitrile containing 0.1% HCOOH. The proportion of water/acetonitrile was 80:20. Ionization of analytes was obtained in the positive ion chemical ionization mode. Fragmentation was obtained using nitrogen as the collision gas. The MS was operating in the multiple reaction mode. The high-performance liquid chromatography column was a Keystone BETASIL 8, 2-mm x 100-mm, 5-~m particle size column. Flow rate was 200 ~L/min with a 10 ~L sample loop volume.
The electrospray process produced a molecular species (MH+) for each parent compound determined, such that for codeine, morphine, and MAM the fragment selected in the first quadrupole (Q1) was 300.4, 286.3, and 328.4 amu, respectively, and the respective deuterated internal standards for codeine, morphine, and MAM were 303.4, 289.3, and 331.4 amu, respectively. After fragmentation in the collision chamber (Q2), one daughter product ion for codeine (165.1), morphine (165.1), and MAM (165.1) was monitored in the second quadrupole (Q3). The fragmentation of the protonated opiates produced the same 165.1 amu fragment ion. The run time was approximately 10 rain. The instrument was operating using unit resolution on both Q1 and Q3.
The linearity range, the carryover potential, the sensitivity, precision, accuracy, and specificity of the method are determined annually. The linear range of the method was determined by analyzing negative hair specimens spiked with codeine, morphine, and MAM in replicates of 5 at the following concentrations: 0, 0.5, 2.5, 5.0, 10.0, 100, 150, and 200 ng/10 mg hair. The limit of detection (LOD) and quantitation for each analyte in this method was 0.5 ng/10 mg hair, for codeine, morphine, and MAM. Precision was determined by analyzing 3 replicates at 5 concentrations. All percent coefficient of variations at the respective points determined were less than 5%. The method was modified from Cailleux et al. (12) . * % B/Bo is the response of the unknown divided by the response of the zero-drug reference, expressed as percent. * The wash criterion is determined by subtracting 5 times the amount of drug in the last of 5 buffer washes from the amount of drug in the hair. If the result is less than the cutoff (2 ng/10 mg hair), the result is considered negative.
Poppy seed
The poppy seed study was performed with Australian poppy seed, because these were shown at that time to contain the highest morphine content of any on the American market (13, 14) according to El Sohly et al. (15) . Two aliquots of seed were analyzed by LC-MS-MS utilizing a 0.1N HCI extraction method (13) . Deuterated internal standards of morphine, MAM, and codeine were used. The average morphine concentration of 325 t~g/g seed was substantially greater than that reported in the literature cited previously. A professional baker (Your Desserts, Malibu, CA) was contracted to bake a poppy seed pastry according to a typical Czeckoslovakian recipe. In order to protect the morphine content of poppy seed, a recipe was chosen in which only the pastry was exposed to high temperatures of 350~ but not the crushed poppy seed filling. Typically, the recipe calls for 25 g of poppy seed per serving. This turned out to be contained in a quantity of pastry which all study participants felt was close to the limit of daily consumption.
Ten test subjects were enrolled in the study, 6 males and 4 females. All test subjects provided consent forms and were enrolled ao cording to the procedure described later. Each test subject was required to eat two servings of poppy seed pastry per week (generally on Monday and Tuesday) for a period of 3 weeks. Total poppy seed consumption per test subject was 150 g (about 49 mg morphine total, 8.1 mg morphine per serving). Test subjects provided a hair specimen before the study, and on the first day, urine specimens were collected over the first 24-h pe- 
Results
Methadone clinic subjects and non-users
Thirty of the 60 clinic subjects with morphine-positive urine tests did not contain MAM in the urines above 10 ng/mL. Both hair and urine results for these subjects are shown in Table I . Table II shows the results of the 39 subjects whose urine samples contained MAM. The range of the morphine levels for all the hair samples in both tables is from 3.1 to 558.9 ng/10 mg hair, while the range of MAM is from 0.8 to 527.2 ng/10 mg hair. All samples also contained codeine, ranging from 0.9 to 121.6 ng/10 mg hair.
Because heroin is an expected external contaminant of hair, which readily hydrolyzes to MAM, extensive washing is important to remove both heroin and MAM when they are present as contaminants rather than due to ingestion. This washing also removes drug present on the hair from sweat, which has been shown to generally contain more heroin and MAM than morphine (16) . Some authors have expressed concern about removal of analyte due to ingestion when extensive washing methods are employed (17) ; however, our resuits show no negative results of confirmed samples among the 69 screen-positive hair samples after washing. Lower MAM values in hair samples that have been extensively washed, as by our wash procedure, would not be surprising. However, no samples from known heroin users lacked MAM. The screening assay is performed on unwashed samples, so any loss of positives due to washing could also be demonstrated by obtaining negative confirmation results on washed hair samples that were positive in the screening assay where the samples are unwashed. This did not occur. One sample (Subject 29) in Table I , however, contained 3.1 ng morphine/10 mg hair, but also contained 0.6 in the last wash. By application of the wash criterion (see Methods, previously), this sample would have to be reported as negative for drug use in workplace testing. The subject, a 260-pound African-American male, had screened positive by RIA for cocaine, marijuana, and opiates. The urine was confirmed to contain morphine just over the cutoff at 2079 ng/mL, but did not contain MAM. The subject's self-report admitted opiate use, but did not provide dose estimates.
Non-user samples
Seventy-one Psychemedics employees who tested negative by urinalysis for all drugs twice per week for 5 weeks had hair samples taken in the sixth week. All hair samples from these subjects tested negative in the RIA screening assay for opiates. These samples all confirmed negative for morphine and MAM by LC-MS-MS. Table III shows LC-MS-MS-determined morphine and MAM results from the washed head hair samples from workplace subjects that screened positive in the RIA (2 ng/10 mg hair cutoff). Also included are results from samples that contained less than 2 ng/10 mg morphine as well as those at or above the cutoff. At very low levels of morphine, the number of samples also containing MAM is low: 3.7 and 8.3% at 0.2 to 0.3 and 0.4 to 0.5 ng morphine/10 mg hair, respectively. As the cutoff is approached, the percent of samples also containing MAM increases. There is clear evidence of heroin use in the region below the cutoff of 2 ng morphine/10 mg hair, as shown by the presence of MAM. Indeed, in the case of samples from 1.5-1.9 ng morphine, 63.6% of samples contain MAM. Of the 51 workplace samples that contained less than 2 ng morphine/10 mg hair, 14 contained more than 2 ng MAM/10 mg hair. These results suggest that the current cutoffs for morphine and MAM may not detect some low heroin users. In our clinical study discussed previously, however, all proven users (with confirmed urines) were detected at a cutoff of 2 ng/10 mg hair. proposed SAMHSA guidelines for workplace drug testing have recommended reporting MAM-positive samples only if they also contain morphine at or above the cutoff; an alternate recommendation is to report as positive a sample with MAM at or above the cutoff if morphine is present at or above the LOD.
Workplace opiate-positive samples
With samples containing morphine above the cutoff of 2 ng/10 mg hair, there is a gradual increase in the percent of samples positive for MAM. The samples averaged about the same amount of MAM as morphine, but with wide variability, as shown in Table III .
Morphine in workplace samples containing codeine
Using the results of opiate analysis of hair in workplace samples, it was possible to investigate the likelihood that morphine was present in hair as a result of codeine ingestion. For this purpose, samples containing large amounts of codeine but no MAM were selected. Table IV shows a set of 117 hair codeine values ranging from 20 to 182 ng codeine/10 mg hair. The first row shows 21 samples that contain high concentrations of codeine, from 20.1 to 66.9 ng codeine/10 mg hair (and no morphine). These results provide evidence that morphine is unlikely to occur in hair as a result of codeine ingestion.
Regarding the additional samples containing high codeine amounts and very small amounts of morphine, it is quite likely that the morphine was present due to prescription use of morphine. In many cases of prescription opiate use, a patient may be given morphine during hospitalization and then be provided codeine or another opiate when no longer hospitalized. But if we make the assumption that no morphine use occurred, we could then interpret the morphine present as the maximum amount of morphine that could possibly be present in hair from codeine use.
Thus, in the next cluster of 20 results in Table IV , containing 0.1-0.2 ng morphine/10 mg hair, the amount of morphine produced averages only 0.63% of the codeine present, with codeine values ranging from 21 to 57.7 ng/10 mg hair. Because 1 standard deviation (SD) is 0.22, the maximum morphine produced (mean + 3 SD) could be as high as 1.29%, which would not exceed the cutoff of 2 ng morphine/10 mg hair unless codeine was present at 155 ng/10 mg hair. This set of results (top two rows in Table IV) , 41 results with morphine from 0-0.2 ng/10 mg hair in samples containing from 20.1 to 66.9 ng codeine/10 mg hair, can be taken as clear evidence that morphine is unlikely to be present in hair above the cutoff from codeine use in washed hair samples. Increasing amounts of morphine are shown in the next groups of samples in Table IV ; in the unlikely event that these subjects are not morphine users, they would provide a maximum estimate of morphine production from codeine. The entire group of 117 samples not containing MAM have a mean of 1.32% morphine relative to codeine [+ 1.09 (1 SD)], with the median at 1.22%. However, among the 117, there were 7 samples with 3.5--4.9% morphine relative to codeine; if these are considered outliers (because they are greater than 2 SDs of the mean and could well be subjects who consumed some morphine), then the mean morphine of the remaining 110 samples is 1.14% of the codeine values (+ 0.84), with a median of 1.13. If the maximum mean % morphine from codeine is estimated to be 1.14% plus 3 SDs, that gives a maximum of 3.7% formation of morphine from codeine. Thus for any value of codeine less than 54 ng/10 mg hair, any morphine present can be assumed to not result from codeine ingestion. However, as seen previously from the results of the low morphine samples (0-0.2 ng/10 mg hair), for samples above 54 and at least up to 154 ng codeine/10 mg hair, it is also highly unlikely that the morphine came from codeine. The lack of morphine in hair due to codeine ingestion in humans agrees with other reports in the literature (17) .
Poppy seed study
The high urine morphine values of the test subjects who ingested poppy seed demonstrate they had absorbed significant quantities of morphine from the consumed poppy seeds ( Table  V) . The maximum values for the subjects ranged from 2,929 to 13,857 ng morphine/mL by MS. More importantly, urine levels remained above the 2000 ng/mL morphine cut-off level for as long as 10 h, as shown by the excretion curves after two of the doses for one subject (Figure 1 ). These high urine values are consistent with those reported by other investigators (8) (9) (10) 15) , and explain the fact that seven of the 10 test subjects in our study reported slight drowsiness I h after consumption of the poppy seed pastries. The drowsiness lasted for approximately 2--4 h. In spite of the relatively high urine morphine values, all test subjects produced morphine levels in hair well below the cut-off level. MAM was not detected in any of the hair specimens. The washes of the 10 hair samples after poppy seed consumption were negative for morphine and MAM. Morphine concentrations in the hair of these subjects, who had consumed 50 g of poppy seed (containing 49 mg of morphine) weekly for 3 weeks, ranged from 0.04 to 0.48 ng morphine/10 mg hair (Table V) , with an average of 0.17 ng/10 rag. Hair samples from three of the 10 subjects after 3 weeks of poppy seed ingestion contained codeine: two contained 0.09 ng/10 mg hair and one contained 0.25 ng/10 mg hair. The experiment demonstrated that consuming high-morphine content poppy seeds on a regular basis produced morphine levels in hair well below the cutoff level of 2 ng/10 mg hair. 
Discussion
Authors of recent papers on analysis of opiates in hair have raised some important issues regarding methodology and utility of hair analysis for opiates (7, 17) . Results from a study that did not include a washing procedure and produced low recoveries of analytes from hair prompted a conclusion that hair was "a poor matrix in (heroin) recidivism monitoring" (7) . The authors of that conclusion discount the need for washing to remove contamination in opiate analysis, and contend that both washing and digestion methods may introduce "analytes of interest" into the sample (17) . They also argue that overnight acetonitrile extraction at room temperature was a sufficiently efficient method to recover the analytes in order to make the above conclusion.
The first premise in discussing these issues is to agree that the goal of hair analysis for opiates is to determine whether an individual used opiates, and to accomplish this by quantifying the amount of drug in the hair. At a minimum, this will determine whether or not the subject's hair contains drug at or above the cutoff, currently proposed by SAMHSA to be set at 2 ng/10 mg hair (200 pg/mg hair). If there were no possibility of external contamination affecting such results, then there would be no need to be concerned with washing hair. However, with respect to opiates, heroin occurs in the environment of the user and cannot be assumed to never contact the hair of anyone, user or nonuser, in that environment. Heroin is known to hydrolyze to MAM, and MAM to morphine. In a recent demonstration of this with four hair samples from heroin users (16) , MAM was found in high quantities in the washes of all 4 samples, and morphine in three of the four. Thus, a procedure to protect against such environmental drug contamination is required for opiate analysis in hair. Without such a procedure, contamination of hair of a nonuser would lead to a false positive, and contamination of a user's hair would lead to erroneous quantitation of the amount in the hair due to ingestion. Therefore, except where cutoffs are not used and the analysis is only to indicate exposure to drug rather than ingestion, failure to address contamination is not an option.
Depending on the purpose of the analysis, removal of drug deposited on the hair from drug-containing sweat is important to obtain an accurate record of a subject's ingestion history. Sweat production varies greatly among individuals, depending on such factors as gender, exertion, stress, climate and season, hormonal status, clothing, or nutritional and hydration states. Compounding the variations in sweat production, the kinds and frequencies of shampoo and conditioner treatments used with different hairstyles also affect the amount of sweat residues left on hair. In addition, the effects of an individual's sweat exposure on his/her own hair can vary greatly for different hair types. For example, porous hair may easily soak up many times more drug than nonporous hair (19) . For meaningful hair analysis results, such drug needs to be removed by effective, extended washing procedures.
Another of the concerns raised by the authors of the recidivism paper is that by washing the hair before extraction, drug from ingestion may be lost to the wash (17) . Reviews of opiate analysis demonstrate relative difficulty in extracting morphine from hair (3, 20) . For example, the recommended methanolic method requires an overnight incubation at high temperature (3) , and the use of water as an extraction solvent was shown to be comparable to methanol in time and temperature requirements (20) . These results are convincing evidence that a few hours of aqueous washing at mild temperatures will not remove significant amounts of drug deposited within the hair from ingestion. In addition, in the results presented in this paper, after three 30-min and two 1-h washes in dilute phosphate buffer, heroin/methadone clinic subjects showed substantial amounts of morphine, MAM, and codeine remaining in their hair, the amounts being comparable to those other investigators (4-6). Somewhat less MAM, relative to morphine, may be expected in washed samples because both MAM in sweat and heroin/MAM from environmental contamination have been removed by washing.
Regarding the concern that wash procedures might produce "analytes of interest that are not due to drug use", it is inconsistent to deliberately not remove potential extraneous contamination at the same time as expressing concern about analytes being present that are not due to use. If the concern is hydrolysis of MAM to morphine at pH 6 for three 30-min washes, this has been shown to be minimal, certainly less than the hydrolysis during 6 h of digestion (7.9%). In the washing procedure used in this laboratory, the successive washes containing contaminating heroin, MAM, and any formed analytes are removed from the sample and thus excluded from the analysis. This is, in fact, the purpose of the wash procedure.
To our knowledge there is no evidence in the literature to support acetonitrile as an acceptable solvent for extraction of opiates from hair. As stated previously, in his review of extraction methods, Staub recommended overnight methanolic methods or enzymatic digestion for maximum recoveries (3) . A review of solvent methods by Rothe and Pragst agreed with the choice of methanol (20) . This laboratory utilizes a proteinase K/dithiothreitol digestion for 6 h at 37~ which we show in this paper to hydrolyze only 7.9% of MAM to morphine. Digestion has been shown by this laboratory (and, incidentally, by the authors using acetonitrile) to recover up to 10 times more drug than the method using acetonitrile (17) . In our critique of the study on hair analysis in recidivism monitoring (17) , we showed that applying the acetonitrile extraction method to washed hair recovered almost no analytes relative to the analyte recoveries upon digesting the same samples that had already been extracted with acetonitrile. This result was in agreement with Rothe and Pragst, who showed that 2 h of sonication of hair in acetonitrile recovered less than 10% of morphine, MAM, or codeine (20) . In their response to our critique, the authors still did not wash the hair samples, and thus showed a highly variable 3-27% recovery of the MAN and morphine relative to recoveries after digestion. Because they still had not washed the hair, it is likely that the MAM and morphine in their acetonitrile fractions were primarily from contamination. In defense of their conclusions regarding hair testing in heroin recidivism monitoring, they conclude that acetonitrile can extract morphine from human and rodent hair. However, such a conclusion is not warranted from their experiment. Even if some analytes were recovered, defending such low recoveries of the analyte of interest as necessary to avoid "potential analytical artifact during enzymatic digestion" is hard to defend--as their concern was the hydrolysis rate of MAM to morphine in the digestion, which is only 7.9% in our laboratory. If the object is to obtain the most accurate results (i.e., results indicating use/no use and a measure of dose) best practice laboratory procedures would dictate optimizing all aspects of the method, especially recovery as well as preservation of the analytes.
The large number of opiate results presented in this report, from negative subjects, heroin users, workplace testing subjects, and in a controlled study of poppy seed use, attest to the utility of hair analysis in measuring opiate use. Besides providing a range of expected values for these various populations, values that agree generally with methods that have used methanolic extractions, we have also shown that with the methods used in this laboratory, morphine is highly unlikely to occur in head hair due to either poppy seed or codeine use.
